BeOne Medicines Ltd.
ONC
41 insider filings · Latest: Jun 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | May 27 9:26 PM | Margaret DuganDirector | Sale | 212 | $309.60 | $65.6K | 0(D) | View → |
| May 22, 2026 | May 27 9:26 PM | Corazon (Corsee) D. SandersDirector | Sale | 212 | $309.59 | $65.6K | 0(D) | View → |
| May 22, 2026 | May 27 8:54 PM | BAKER BROS. ADVISORS LPDirector | Sale | 10,998 | $23.82 | $262.0K | 142,570(I) | View → |
| May 22, 2026 | May 22 8:28 PM | MICHAEL GOLLER | Proposed Sale | 211 | $310.07 | $65.4K | — | View → |
| May 22, 2026 | May 22 8:25 PM | RANJEEV KRISHANA | Proposed Sale | 212 | $309.28 | $65.6K | — | View → |
| May 22, 2026 | May 22 8:22 PM | ALESSANDRO RIVA | Proposed Sale | 212 | $309.51 | $65.6K | — | View → |
| May 22, 2026 | May 22 8:20 PM | MARGARET DUGAN | Proposed Sale | 212 | $309.60 | $65.6K | — | View → |
| May 22, 2026 | May 22 8:18 PM | CORAZON D. SANDERS | Proposed Sale | 212 | $309.59 | $65.6K | — | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Sale | 332 | $310.72 | $103.2K | 0(D) | View → |
| May 13, 2026 | May 13 8:27 PM | CHAN LEE | Proposed Sale | 1,328 | $315.07 | $418.4K | — | View → |
| Apr 8, 2026 | Apr 10 9:40 PM | Chan Henry LeeSVP, General Counsel | Sale | 332 | $311.59 | $103.4K | 0(D) | View → |
| Mar 11, 2026 | Mar 13 9:26 PM | Chan Henry LeeSVP, General Counsel | Sale | 341 | $300.00 | $102.3K | 0(D) | View → |
| Feb 4, 2026 | Feb 6 9:57 PM | Chan Henry LeeSVP, General Counsel | Sale | 1,660 | $349.52 | $580.2K | 0(D) | View → |
| Feb 4, 2026 | Feb 4 9:21 PM | CHAN LEE | Proposed Sale | 4,676 | $346.38 | $1.6M | — | View → |
| Dec 15, 2025 | Dec 15 9:32 PM | JOHN V OYLER | Proposed Sale | 100,000 | $319.06 | $31.9M | — | View → |
| Nov 26, 2025 | Nov 26 9:13 PM | CORAZON D. SANDERS | Proposed Sale | 2,627 | $340.90 | $895.5K | — | View → |
| Nov 17, 2025 | Nov 17 9:16 PM | XIAOBIN WU | Proposed Sale | 3,991 | $380.43 | $1.5M | — | View → |
| Nov 13, 2025 | Nov 13 9:22 PM | XIAOBIN WU | Proposed Sale | 6,009 | $380.54 | $2.3M | — | View → |
| Nov 12, 2025 | Nov 12 10:04 PM | XIAOBIN WU | Proposed Sale | 10,000 | $356.02 | $3.6M | — | View → |
| Oct 8, 2025 | Oct 8 8:19 PM | CHAN LEE | Proposed Sale | 13,659 | $341.62 | $4.7M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
| Apr 8, 2026 | Apr 10 9:40 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 109,122(D) | View → |
| Mar 11, 2026 | Mar 13 9:26 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,433 | — | 110,396(D) | View → |
| Feb 4, 2026 | Feb 6 9:57 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,580 | — | 111,670(D) | View → |